Exosome-Based Drug Development Services for Liver Disease

Ace Therapeutics aims to provide the most reliable research services to liver disease drug development investigators worldwide. We have extensive hands-on experience in the field of liver disease drug development. With our excellent experts and professional technology platform, we provide the most scientific research services for your study.

Exosomes have a wide range of physiological functions and play an important role in information exchange and intercellular material transfer in particular. Exosomes play an important role in disease diagnosis and drug delivery. Recent studies have shown that some exosomes can effectively alleviate liver disease, which is a potential avenue to develop new therapies for liver disease. We offer a comprehensive service for the development of exosome-based drugs for liver disease.

What Can We Do?

In view of the rich biological activity of exosomes, we offer comprehensive drug development services for their different regulatory roles in liver disease processes with a view to maximizing the potential of exosomes in the therapeutic field of liver disease.

• We have a standard exosome analysis process that ensures robust and standardized characterization of exosomes from different sources to ensure the accuracy of experiments.
• Given those hepatocyte-derived exosomes are involved in multiple pathogeneses of liver diseases, such as stimulating leukocytes, we have developed comprehensive services to screen and identify exosomes with therapeutic effects.
• Given the role of hepatic stellate cell-derived exosomes in promoting pathological processes such as liver fibrosis and hepatocellular carcinoma, we will screen for differentially expressed exosomal miRNAs by gene microarray technology and further screen for exosomes with therapeutic effects.
• Given the impact of exosomes on liver regeneration, we will provide gene microarray technology and protein microarray technology to screen for liver regeneration-promoting exosomes and further develop their drug potential.
• For the anti-inflammatory activity of MSC-derived exosomes, we will widely screen for exosomes with anti-inflammatory effects and evaluate and develop their medicinal value by mass spectrometry, microarray technology, and microarray technology.
• For different exosomes, we will offer perfect services in maintaining the homogeneity of exosomes to produce fewer side effects while treating liver diseases.
• Given the complex physiological activities of exosomes, we will perform comprehensive activity evaluation services of potential drug candidates to ensure the safety of the candidate exosomes for the organism.

Ace Therapeutics has rich research experience in the field of liver disease drug development. We have a perfect service system for liver disease model construction, exosome identification, and exosome activity evaluation. We can provide you with the most professional service. Please contact us, and don't hesitate to let us know if we can be of any assistance to you.

Reference

1. Jiao, Y., et al., Advances on liver cell-derived exosomes in liver diseases. J Cell Mol Med, 2021. 25(1): p. 15-26.

Our products and services are for research use only and can not be used for diagnostic or other purposes.